Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dyslipaemia, Atherosclerosis Risk and Increased hsCRP and Inflammatory and Oxidative Status in the Spanish Population

NCT00998062 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00998062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00998062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dyslipaemia, Atherosclerosis Risk and Increased hsCRP and Inflammatory and Oxidative Status in the Spanish Population
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 30, 2009
Completion date
October 31, 2011
Enrollment
30,181 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis risk, dyslipaemia, increased hscrp, inflammatory and oxidative status in the spanish population